Abstract: Although tremendous progress has been made in the diagnosis of melanoma, the identification of different stages of malignancy in ar eliable wayr emains challenging.C urrent strategies rely on optical monitoring of the concentration and spatial distribution of specific biomarkers.S tate-of-the-art optical methods can be affected by background-color interference and autofluorescence.W eo vercame these shortcomings by employings canning electrochemical microscopy( SECM) to map the prognostic indicator tyrosinase (TyR) in nonmetastatic and metastatic melanoma tissues by using soft-stylus microelectrodes.E lectrochemical readout of the TyRd istribution was enabled by adapting an immunochemical method. SECM can overcome the limitations of optical methods and opens unprecedented possibilities for improved diagnosis and understanding of the spatial distribution of TyRi nd ifferent melanoma stages.
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Melanoma is one of the most lethal cutaneous malignancies,a nd strikes about 132 000 people per year worldwide. [1] Earlier stages of melanoma (stages 0, Ia nd II) can be cured. However,the survival rate decreases drastically for metastatic melanoma (stages III and IV) because the cancer has already invaded the lymph nodes and other organs. [2] Consequently, surgery and adjuvant therapies including immunotherapy or chemotherapy may be applied. Reliable methods for the unequivocal identification of cancer metastasis are of high relevance.T he similar appearance of melanoma and innocuous skin moles impedes easy cancer identification. The prevalent method to confirm malignancyi sb ased on the detection of specific biomarkers on biopsies by immunohistochemistry (IHC) combined with pathological analysis.I n IHC,b iomarkers are typically visualized optically by immunoassays with functionalized labels (e.g.,h orse radish peroxidase (HRP) or fluorescent tagging molecules). However, optical methods often suffer from practical limitations that potentially lead to uncertain conclusions.F or instance, melanin can resemble the color of the chromogen 3,3'-diaminobenzidine (DAB), which is commonly employed in IHC ( Figure S1 in the Supporting Information).
[3] Alternatively,f luorescent tagging could be impeded by cellular autofluorescence or photobleaching. [4] Electrochemical methods may represent ap romising alternative since they rely exclusively on the electrochemical detection of redox-active species related to the presence of biomarkers.Scanning electrochemical microscopy (SECM) is asurface reactivity mapping tool with high spatial resolution and sensitivity that has been used widely for studying living cell cultures [5] but rarely for tissues.F or instance,e nzymatic activity and oxygen production/consumption in plant tissues and microtissues have been monitored. [6] SECM has also been applied to study molecular transport through skin samples. [7] Thelateral dimensions of tissue samples can approach square centimeters and height differences can be in the critical domain of the SECM probe.S ince the probe-sample interaction depends on the working distance d data interpretation from uneven samples can become cumbersome.A n uncontrolled d can lead to probe-sample crashes when scanning closely over atissue,leading to irreparable damage to the specimens and contamination of the sensing probe.The former is especially true when using microelectrodes (ME) enclosed in ahard insulating glass body.
In this work, we present SECM for precise mapping of the tyrosinase (TyR) distribution in formalin-fixed, paraffinembedded tissue microarrays (TMA) of skin biopsies taken from nine patients.T yR is ac opper-containing enzyme that controls the production of melanin, [8] and it can be used as ah ighly selective indicator for the prognostic diagnosis of melanoma. [9] Recently,this has been demonstrated for biopsy samples analyzed in an electrochemical biosensor platform. [10] In this work, an immunodetection strategy for Ty Rw as adapted for the monitoring of melanoma stages through the electrochemical detection of TMB ox ,w hich is the enzymatic reaction product of tetramethylbenzidine (TMB), H 2 O 2 ,a nd HRP (Scheme 1a). [11] Soft ME probes capable of scanning delicate samples with topographic sample features in agentle brush-like contact mode and at constant d were employed (Scheme 1b). [12] These soft SECM probes were previously introduced by our group for simple and affordable constantdistance control. Alternative approaches require the combination of SECM with technically and experimentally sophisticated distance-control tools.
[5b, 13] Figure 1a shows SECM line scans over skin biopsy sections from three different patients containing melanoma stages II (non-metastatic) and III (metastatic), and normal skin tissues.Aconventional Pt ME in constant-height mode was employed by adjusting d with respect to the glass support of the TMA and not to the tissue surface (experimental details in Section SI-2;line scan directions in Figure S3) . The highest expression level of Ty Rwas observed in stage II tissue samples.Alower level of Ty Rw as found in normal skin, where Ty Ri sp roduced at moderate levels by melanocytes located in the bottom layer of the epidermis.Asitcan be seen in Figure 1a ,o ver the stage III tissue section, much lower currents than the baseline current (defined as the hindered diffusion current measured over the insulating glass substrate) were detected. Diffusion of the redox-active species towards the ME was significantly blocked owing to av ery small d over the relatively thick stage III tissue.T his observation is supported by topographic measurements of the tissue samples recorded in ah ydrated state in the experimental solution ( Figure S4 ). Stage III samples showed stronger swelling and thus am ore pronounced height. As ar esult, correct interpretation of the measured constant height SECM data over aT MA is challenging. Therefore, tissue sections can only be investigated individually in contactless mode by adjusting d subsequently over each section ( Figure S5 ). Moreover,c onstant-height-mode scanning over such large samples can induce microscratches or partially detached tissue material upon am echanical MEtissue contact ( Figure S6 ). To overcome these drawbacks,s oft-stylus probes (see Section SI-2) were employed for the contact-mode scanning of biopsies from another six patients (Figure 1b,c and Figure S3) . It is worth mentioning that the tissue sections were not damaged during the contact-mode scanning thanks to the weak forces exerted by the soft probe on the sample ( Figure S7 ). [14] In addition, all six tissue sections and the obtained data demonstrate the reproducibility of the SECM approach among samples from different persons.T he different Ty Rl evels (stage II > normal skin) were identified with high certainty and sensitivity.S tage III melanoma shows aslightly lower Ty Rcontent over the entire tissue section than stage II. It has been reported previously that the TyR distribution in stage III melanoma is heterogeneous, [11b] and in consequence,s ingle SECM line scans are not representative.
Therefore,S ECM images of normal skin, as well as of melanoma stages II and III sections,w ere recorded and compared with tissues examined by the conventional IHC method (Figure 2 ). TheS ECM image in Figure 2a clearly indicates ah omogeneous overexpression of TyRi ns tage II and ah eterogeneous distribution in stage III melanoma. Tu mors tend to develop different mechanisms of immunosuppression to avoid being destroyed by the immune system. [15] Shedding or mutation of the tumor antigens is one strategy that facilitates tumor escape from the immune system, leading to tumor proliferation and metastasis.A s atumor-associated antigen, TyRisrecognized by the immune system and thus agradual loss of Ty Rcould be of benefit for tumor escape.A saconsequence,t he Ty Rd istribution is heterogeneous and slightly decreased in stage III melanoma in accordance with our presented data. In normal skin tissue, the Ty Rc ontent increased slightly towards the basal epidermis,w here normal melanocytes are located. Theo bserved polarity of Ty Rdistribution is in agreement with reports in the literature.
[11b] Because other Ty Rd istribution patterns than the one shown are known to be asign of different Ty R-related dermal diseases,the presented SECM approach could provide further screening applications.T he specificity of the Ty R immunoassay was confirmed by applying the method without primary antibodies (Abs), which showed an insignificant contribution from non-specific binding ( Figure S8 ). In conventional IHC,T yR is labeled with aspecific pink chromogen (Section SI-2) and thus its detection is strongly interfered with by melanin in stage III melanoma (Figure 2c ). By contrast, the electrochemical detection of Ty RbySECM is not affected by colored background samples ( Figures S1, S7) .
Thei mportance of mapping the local TyRd istribution becomes apparent when averaging the currents from nine representative locations in each tissue section to reflect the global Ty Rconcentration (see Figure S9 ). In the column plot in Figure 2e ,S tage II melanoma shows the highest average current, followed by normal skin and stage III melanoma. Hence,t he lower currents for stage III melanoma could be interpreted wrongly as normal skin. However, as can be seen from the SECM image and its 2D plot (Figure 2f) , the lower average current for stage III is aresult of heterogeneous Ty R distribution. Locally,the SECM currents were higher than in stage II. SECM imaging visualizes the abnormal distribution of the TyR(not in the basal layer of epidermis) and confirms the correct identification of stage III melanoma tissue samples.This shows the limitation of traditional sensors that only measure the global concentration of ac ertain biomarker, while demonstrating the advantage of spatial resolution. Discrimination between stage II and stage III melanoma is of high relevance because it drastically influences the medical treatment in terms of chemotherapy,immunotherapy,orT yR DNAvaccine therapy (Section SI-10). [16] In conclusion, SECM on skin biopsies from different melanoma patients allows accurate monitoring of TyR expression and distribution in distinct melanoma stages.A n immunoassay was employed to distinguish melanoma stages II and III by using soft SECM probes for gentle contact-mode brushing of the delicate tissue samples. Thep rogression from ah omogeneous Ty Rdistribution in stage II to ah eterogeneous one in stage III was clearly visualized and in comparison with IHC,t he SECM concept is not limited by the presence of optically interfering species,such as melanin. Hence,SECM mapping of Ty Rm ight be implemented directly or as ac omplementary prognostic technique for diagnosing metastatic and non-metastatic melanoma stages.S oft ME arrays will accelerate the analysis to screen cancer tissue libraries of clinically relevant quantities.
[14b,17] Furthermore,t he integration of microfluidic channels into the soft probe could enable advanced control of the surrounding tissue microenvironment for simultaneous electrochemical, fluorescence,a nd mass spectrometry detection. [18] 
